Windtree Therapeutics Inc Stock Ownership - Who owns Windtree Therapeutics?

Insider buying vs selling

Have Windtree Therapeutics Inc insiders been buying or selling?
Craig FraserPresident and CEO2023-04-261,497$1.77
Craig FraserPresident and CEO2023-04-251,315$1.89
James HuangDirector2023-02-221,112,308$0.14
Craig FraserPresident and CEO2022-07-272,500$0.38
Craig FraserPresident and CEO2022-07-262,500$0.37
John P. HamillSVP & CFO2022-07-263,000$0.37
Craig FraserPresident and CEO2022-06-304,500$0.43
Craig FraserPresident and CEO2022-06-297,000$0.42

1 of 1

WINT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when WINT insiders and whales buy or sell their stock.

WINT Shareholders

What type of owners hold Windtree Therapeutics Inc stock?
Lph Investments Ltd898.07%46,232,085$64.26MInsider
Lees Pharmaceutical Holdings Ltd337.43%17,370,770$24.15MInsider
China Cardiovascular Focus Ltd156.64%8,063,861$11.21MInsider
James Huang119.52%6,152,576$8.55MInsider
Panacea Venture Healthcare Fund I LP87.95%4,527,345$6.29MInsider
Ivy Blue Holdings Ltd84.24%4,336,790$6.03MInsider
Lph Ii Investments Ltd77.86%4,008,234$5.57MInsider
Center Laboratories Inc48.14%2,478,176$3.44MInsider
Robert J. Capetola8.48%436,417$606.62kInsider
Christopher J. Schaber4.52%232,771$323.55kInsider

1 of 3

WINT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
WINT0.00%100.00%Net BuyingNet Buying
SILO2.76%5.15%Net BuyingNet Buying
AYTU1.80%98.20%Net Buying

Windtree Therapeutics Stock Ownership FAQ

Who owns Windtree Therapeutics?

Windtree Therapeutics (NASDAQ: WINT) is owned by 0.03% institutional shareholders, 1,841.39% Windtree Therapeutics insiders, and 0.00% retail investors. Lph Investments Ltd is the largest individual Windtree Therapeutics shareholder, owning 46.23M shares representing 898.07% of the company. Lph Investments Ltd's Windtree Therapeutics shares are currently valued at $64.26M.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.